Methylxanthine therapy in premature infants: Sound practice, disaster, or fruitless byway?
- 31 October 1999
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 135 (4) , 526-528
- https://doi.org/10.1016/s0022-3476(99)70180-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Predictors of Early School Age Outcomes in Very Low Birth Weight ChildrenJournal of Developmental & Behavioral Pediatrics, 1998
- Adenosine, Adenosine Receptors and the Actions of Caffeine *Basic & Clinical Pharmacology & Toxicology, 1995
- Comparison of the effects of acetazolamide and aminophylline on apnea incidence and on ventilatory response to CO2, in preterm infantsPediatric Pulmonology, 1994
- What does the preterm infant breathe for? Controversies on apnea of prematurityActa Paediatrica, 1992
- Recent patterns of drug use in newborn intensive careThe Journal of Pediatrics, 1990
- Does caffeine prevent hypoxaemic episodes in premature infants?European Journal of Pediatrics, 1988
- Outcome of preterm infants who suffered neonatal apnoeic attacksEarly Human Development, 1988
- Cerebral Palsy in Very Low Birthweight Infants Surviving to 2 Years With Modern Perinatal Intensive CareAmerican Journal of Perinatology, 1987
- Neonatal apnea, xanthines, and necrotizing enterocolitisJournal of Pediatric Surgery, 1983
- Aminophylline Increases Cerebral Metabolic Rate and Decreases Anoxic Survival in Young MiceScience, 1978